We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Hofseth Biocare Asa | LSE:0Q6H | London | Ordinary Share | NO0010598683 | HOFSETH BIOCARE ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.00 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 218.51M | -106.68M | -0.2700 | -7.41 | 790.16M |
From Oct 2024 to Dec 2024
Christel Elise Kanli has decided to step down as Chief Financial Officer (CFO) of Hofseth BioCare ASA (“HBC”) to pursue opportunities outside of the company.
"I would like to thank Christel for her efforts and positive contributions to HBC. I wish her all the best of luck in her future endeavors" said Jon Olav Ødegård, CEO of HBC. HBC has initiated a search for Kanli's successor for the CFO position.
Contact details for further information:
Jon Olav Ødegård, CEO
E-mail: joo@hofsethbiocare.no
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. This stock exchange announcement was published by Jon Olav Ødegård, CEO, on the time set out above, on behalf of HBC.
1 Year Hofseth Biocare Asa Chart |
1 Month Hofseth Biocare Asa Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
